a 68930 has been researched along with fenoldopam in 2 studies
| Studies (a 68930) | Trials (a 68930) | Recent Studies (post-2010) (a 68930) | Studies (fenoldopam) | Trials (fenoldopam) | Recent Studies (post-2010) (fenoldopam) |
|---|---|---|---|---|---|
| 63 | 2 | 19 | 657 | 92 | 94 |
| Protein | Taxonomy | a 68930 (IC50) | fenoldopam (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Bos taurus (cattle) | 1.58 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grenader, A; Healy, DP | 1 |
| Christie, MI; Smith, GW | 1 |
2 other study(ies) available for a 68930 and fenoldopam
| Article | Year |
|---|---|
A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Cells, Cultured; Chromans; Cyclic AMP; Dopamine; Dopamine Agents; Epithelial Cells; Epithelium; Fenoldopam; Kidney; Receptors, Dopamine D1 | 1992 |
Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Chromans; Consciousness; Dogs; Dopamine Agents; Fenoldopam; Hemodynamics; Kidney; Male; Receptors, Dopamine D1 | 1994 |